focus -WSS

focus

author：comprehensive 2025-08-12 09:13:27 - browse：12

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

Good morning. Today we have Andrew Joseph’s dispatch from a Barcelona hospital that developed its own CAR-T, an intriguing clue to how obesity drugs work in the (mouse) brain, and a win for toothbrushing vs. pneumonia.

Apple pauses sales of latest watches in patent battle

If you had an Apple Watch on your wish list for the holidays this year, you may need to reconsider. To comply with an import ban from the International Trade Commission imposed in October, Apple is pulling Apple Watches with blood oxygen-measuring capabilities — that is, Apple Watch Series 9 and Apple Watch Ultra 2 — from its website Thursday and from its stores Sunday. The ITC has ruled that Apple infringed on the patents of pulse oximeter company Masimo. President Biden has until Dec. 25 to approve or veto the import ban, but Apple decided to pause sales first. Older versions of the Apple Watch that track heart rate and physical activity will still be available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Why failed clinical trials don’t always spell doom for a new drug

WSS

Why failed clinical trials don’t always spell doom for a new drug

Emergent cuts jobs, executive role in business shake

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Maui's cultural, historic landmarks damaged in the devastating wildfires

leisure time

focus

Apple pauses sales of latest watches in patent battle

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Bright Health sells Medicare Advantage business to Molina

Bernie Sanders gets little from pharma CEOs on drug prices

How to save PrEP access — and even expand it

Congress must protect the remaining independent doctors

BioMarin wins approval for gene therapy to treat hemophilia A

The best solution to the drug shortages problem

The cancer drug shortage isn’t new — and neither are the solutions

FDA panel issues narrow recommendation for Covid vaccine booster doses

entertainment

Long Covid research funding gets a major boost from NIH

Having children helps parents live longer, especially after age 80

Anavex keeps shifting the goalposts in its clinical trials

Long Covid research funding gets a major boost from NIH

Doctors on social media are being harassed and cyberbullied

Doctors on social media are being harassed and cyberbullied

explore

hotspot

knowledge

knowledge